Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects With Alzheimer's Disease Family History
Authors not listed
Augusta University · 2023
Abstract
Investigators' recent findings from the pilot clinical trial in MCI individuals demonstrated EVOO improved vascular function and memory. Yet, up to date, whether EVOO protects against AD in individuals with a family history of AD is unknown. Thus, in this study, the investigators will recruit healthy individuals with a family history of AD for participation. From eligible participants, blood samples for ApoE genotyping will be collected, followed by metabolomics, lipidomics, and transcriptomics analyses at baseline. Participants will be randomized into 2 groups (n=20 each); one group will receive EVOO daily (\~2 tablespoons, 30 ml) for 6 months, and the second group will not receive olive oil. Both group participants will receive educational information on brain health and how environmental factors such as lifestyle, diet, and exercise could impact brain health. After 6 months, another blood sample will be collected from the participants to evaluate the effect of EVOO on metabolites, lipids, and genes, and thus physiological pathways. The investigators will perform non-targeted and comprehensive metabolomics, lipidomics, and transcriptomics analyses. Examples of metabolites to be analyzed are antioxidative and anti-inflammatory metabolites, neurotransmission, mitochondrial, tryptophan, and purine metabolisms. Examples of lipidomics include sphingomyelins (SMs), cholesterol esters (ChEs), phosphatidylcholines (PCs), phosphatidylethanolamines (PIs), phosphatidylinositols (PIs), and triglycerides (TGs). Transcriptomics will be used to identify changes in mRNAs involved in different pathways contributing to AD, such as genes involved in inflammation and oxidative stress, in both ApoE-dependent and independent fashion.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2023). Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects With Alzheimer's Disease Family History. <em>Augusta University</em>. https://clinicaltrials.gov/study/NCT05929924
Vancouver
Anonymous. Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects With Alzheimer's Disease Family History. Augusta University. 2023.
BibTeX
@misc{anon2023DoesEV,
title = {Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects With Alzheimer's Disease Family History},
author = {Anonymous},
journal = {Augusta University},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Calgary 2017
Open access · US-GOV
Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias: Harnessing Translational Physiology
Duke University 2018
Open access · US-GOV
Modulation of Episodic Memory Using Theta Burst Stimulation (TBS)
University of Utah 2016
Open access · US-GOV
Does Practice Beyond Performance Plateau Improve Motor Learning in Healthy Adults?
Parc Sanitari Pere Virgili 2022
Open access · US-GOV
+ AGIL Barcelona: Integrated Care for Community-Dwelling Frail Older Adults
Clemson University 2021
Open access · US-GOV
Assessing Cognitive and Psychosocial Mechanisms of Useful Field of View Cognitive Training Using Ecological Momentary Assessment
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 2018
Open access · US-GOV